Related Experiment Video
Updated: Jul 21, 2025

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation
Published on: February 28, 2012
Adherence, belief, and knowledge about oral anticoagulants in patients with bioprosthetic heart valve replacement: a
Yun-Xia Ni1, Lu-Lu Liu2, Huang Feng3
1Department of Cardiology, West China Hospital, Sichuan University/West China School of Nursing, Sichuan University, Chengdu, China.
Insights
Patients with mechanical heart valves (BHV) show low oral anticoagulant adherence. Improving patient knowledge and beliefs about medication is key to enhancing adherence after BHV replacement.
Area of Science:
- Cardiology
- Pharmacology
- Patient Adherence Research
Background:
- Mechanical heart valve (BHV) replacement procedures are increasing.
- Optimal oral anticoagulant therapy is crucial post-BHV replacement.
- Understanding adherence barriers and facilitators is vital.
Purpose of the Study:
- To assess oral anticoagulant adherence in BHV replacement patients.
- To investigate the mediating role of medication beliefs.
- To explore the link between knowledge and adherence.
Main Methods:
- Cross-sectional study with 323 BHV replacement patients.
- Utilized Morisky Medication Adherence Scale, Beliefs about Medicines Questionnaire, and Knowledge of Anticoagulation Questionnaire.
- Mediation analysis using Hayes's PROCESS macro.
Main Results:
- Only 35.6% of patients reported high adherence to oral anticoagulants.
- Knowledge and necessity beliefs positively influenced adherence.
- Concern beliefs negatively correlated with adherence, with medication belief mediating the knowledge-adherence relationship.
Conclusions:
- Patients with BHV replacement exhibit suboptimal oral anticoagulant adherence.
- Interventions should focus on enhancing patient knowledge and beliefs regarding anticoagulation.
- Addressing medication beliefs is crucial for improving adherence outcomes.
Abstract:
Aims: To investigate adherence to oral anticoagulants among patients after mechanical heart valve (BHV) replacement and further examine the mediating role of medication belief in the relationship between knowledge and medication adherence. Background: The number of patients who undergo BHV replacement has increased in recent years. Short-term anticoagulant therapy is recommended for patients after BHV replacement. However, little is known about adherence to oral anticoagulant therapy and the underlying mechanisms among patients with BHV replacement. Methods: A cross-sectional study was conducted between September 2022 and November 2022. A convenience sample of 323 patients who underwent BHV replacement was recruited from a tertiary public hospital in Southwest China. Data were collected by using the 8-item Morisky Medication Adherence Scale, Beliefs about Medicines Questionnaire-specific, and the Knowledge of Anticoagulation Questionnaire. The mediation model was tested by Hayes's PROCESS macro. The STROBE checklist was used. Results: Approximately 17.3% of participants had low adherence, 47.1% had medium adherence, and only 35.6% reported high adherence to oral anticoagulants. Knowledge and necessity beliefs were positively related to medication adherence, while concern beliefs were negatively correlated with medication adherence. Medication belief mediated the relationship between knowledge and adherence to oral anticoagulants. Conclusion: Patients with BHV replacement demonstrated relatively low adherence to oral anticoagulant therapy. Efforts to enhance medication adherence should consider improving patients' knowledge and medication beliefs.
Related Concept Videos
Venous Thrombosis III: Interprofessional Care
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Endocarditis III: Medical Management
Endocarditis IV: Nursing Management
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...

